ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
7.68
+0.21 (2.81%)
Feb 21, 2025, 4:00 PM EST - Market closed
ORIC Pharmaceuticals Market Cap
ORIC Pharmaceuticals has a market cap or net worth of $545.49 million as of February 21, 2025. Its market cap has decreased by -34.17% in one year.
Market Cap
545.49M
Enterprise Value
298.88M
1-Year Change
-34.17%
Ranking
Category
Stock Price
$7.68
Market Cap Chart
Since April 24, 2020, ORIC Pharmaceuticals's market cap has decreased from $741.98M to $545.49M, a decrease of -26.48%. That is a compound annual growth rate of -6.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 545.49M | -4.21% |
| Dec 31, 2024 | 569.48M | 13.47% |
| Dec 29, 2023 | 501.88M | 89.55% |
| Dec 30, 2022 | 264.77M | -54.26% |
| Dec 31, 2021 | 578.91M | -53.32% |
| Dec 31, 2020 | 1.24B | 67.13% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.21B |
| UnitedHealth Group | 462.37B |
| Johnson & Johnson | 384.45B |
| Novo Nordisk | 370.84B |
| AbbVie | 354.62B |
| Abbott Laboratories | 230.98B |
| AstraZeneca | 227.07B |
| Merck & Co. | 221.80B |